SCHEDULING OF ULTRA-LOW DOSE INTERLEUKIN-2 IN IMMUNOTHERAPY

被引:1
作者
LINDEMANN, A
MERTELSMANN, R
机构
关键词
D O I
10.1016/0959-8049(93)90234-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2336 / 2336
页数:1
相关论文
共 4 条
[1]   SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 [J].
CALIGIURI, MA ;
MURRAY, C ;
ROBERTSON, MJ ;
WANG, E ;
COCHRAN, K ;
CAMERON, C ;
SCHOW, P ;
ROSS, ME ;
KLUMPP, TR ;
SOIFFER, RJ ;
SMITH, KA ;
RITZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :123-132
[2]   IMMUNOMODULATORY EFFECTS OF ULTRA-LOW-DOSE INTERLEUKIN-2 IN CANCER-PATIENTS - A PHASE-IB STUDY [J].
LINDEMANN, A ;
BROSSART, P ;
HOFFKEN, K ;
FLASSHOVE, M ;
VOLIOTIS, D ;
DIEHL, V ;
HECKER, G ;
WAGNER, H ;
MERTELSMANN, R .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (05) :307-315
[3]  
SMITH KA, 1993, BLOOD, V81, P1414
[4]   PROLONGED IMMUNOSTIMULATORY EFFECT OF LOW-DOSE POLYETHYLENE-GLYCOL INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
TEPPLER, H ;
KAPLAN, G ;
SMITH, KA ;
MONTANA, AL ;
MEYN, P ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :483-492